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Near-infrared spectroscopy (NIRS) is used to monitor cerebral tissue oxygenation (rSO2) 
depending on cerebral blood flow (CBF), cerebral blood volume and blood oxygen 
content. We explored whether NIRS might be a more easy applicable proxy to [15O]H2O 
positron emission tomography (PET) for detecting CBF changes during hemodialysis. 
Furthermore, we compared potential determinants of rSO2 and CBF. In 12 patients aged 
≥65 years, NIRS and PET were performed simultaneously: before (T1), early after start (T2), 
and at the end of hemodialysis (T3). Between T1 and T3, the relative change in frontal rSO2 
(ΔrSO2) was -8±9% (P=0.001) and -5±11% (P=0.08), whereas the relative change in frontal 
gray matter CBF (ΔCBF) was -11±18% (P=0.009) and -12±16% (P=0.007) for the left and 
right hemisphere, respectively. ΔrSO2 and ΔCBF were weakly correlated for the left (ρ 0.31, 
P=0.4), and moderately correlated for the right (ρ 0.69, P=0.03) hemisphere. The Bland-
Altman plot suggested underestimation of ΔCBF by NIRS. Divergent associations of pH, 
pCO2 and arterial oxygen content with rSO2 were found compared to corresponding 
associations with CBF. In conclusion, NIRS could be a proxy to PET to detect intradialytic 






Cognitive impairment is highly common in patients with advanced chronic kidney disease 
(CKD). 1 Cognitive performance might be negatively affected by structural brain lesions 
that are often present in the CKD population, including lacunar infarctions, 2 microbleeds, 3  
and loss of white matter integrity. 4, 5 Besides the many risk factors for cognitive decline 
that are present in patients with CKD, the hemodialysis procedure itself might also induce 
brain injury. In patients with advanced CKD, the transition to dialysis has been associated 
with an accelerated decline of cognitive function and an increased incidence of strokes. 6, 7  
Hemodialysis involves repetitive fluid removal, thereby frequently resulting in alterations 
in blood pressure and volume status, which might induce circulatory stress. 8 The fluid 
removal during hemodialysis is accompanied by an increase of blood viscosity, and rapid 
shifts in electrolytes, acid-base balance, and uremic solutes. 9, 10 Furthermore, exposure of 
the blood to the extracorporeal circuit during hemodialysis triggers an inflammatory 
response with complement activation, endothelial activation, and activation of 
coagulation pathways. 11-13 All these processes could theoretically affect the macro- and 
microvascular cerebral blood flow and cerebral oxygenation.  
To unravel potential mechanisms that underlie the link between cognitive 
impairment and the hemodialysis procedure, we previously evaluated whether 
hemodialysis has a direct effect on cerebral blood flow (CBF). Using [15O]H2O positron 
emission tomography (PET), we found that hemodialysis induced a 10% decline in global 
and regional CBF in elderly hemodialysis patients. 14 This CBF decline does not 
automatically imply an impaired autoregulation, because the dynamic pressure-flow 
relationship may also be affected by alterations in cerebrovascular resistance apart form 
autoregulation, such as changes in pH, hematocrit and blood volume during hemodialysis. 
Second, we found that as hemodialysis-related factors a higher pH, higher tympanic 
temperature, and a larger ultrafiltration rate and volume were associated with a lower CBF. 
However, [15O]H2O PET-scanning involves radiation, requires an on-site cyclotron for 
nuclide generation, and is complicated to perform during a hemodialysis session. 
Therefore, there is a need for an alternative method that is easier to apply to monitor 
changes in cerebral perfusion during hemodialysis. 15   
A technique that has been proposed to monitor the adequacy of cerebral perfusion 
is non-invasive near-infrared spectroscopy (NIRS) by measuring frontal cerebral tissue 
oxygenation. 16 During hemodialysis, relative drops of more than 15% in frontal cerebral 
tissue oxygenation (rSO2) were associated with decreased executive cognitive function one 
year after the start of hemodialysis. 17 Changes in frontal rSO2 are commonly considered to 
	
reflect changes in (frontal) CBF, 18, 19 but whether an intradialytic decline in frontal rSO2 
reflects a simultaneous and similar fall in frontal CBF is unknown.  
In this study, we aimed to evaluate whether changes in frontal cerebral 
oxygenation can identify changes in frontal CBF during hemodialysis. In detail, we 
investigated (i) the correlation and agreement between intradialytic changes in frontal 
rSO2 and frontal gray matter CBF, and (ii) how hemodialysis and oxygenation-related 
factors and markers of inflammation and endothelial activation are associated with 
changes in rSO2, as compared to CBF.  
 
MATERIALS AND METHODS 
 
Ethics 
The study was performed according to the principles of the Declaration of Helsinki and 
was approved by the Medical Ethical Committee of the University Medical Center 
Groningen, and registered at clinical trials.gov (NCT02272985). All patients gave written 
informed consent.  
 
Study design and patient recruitment 
The study was performed between March and November 2015 and comprised two 
objectives: (i) to evaluate the effect of hemodialysis on cerebral perfusion, which was 
published recently, 14 and (ii) to study the correlation between changes in frontal rSO2 and 
changes in frontal and global CBF, as measured by [15O]H2O PET-CT.  
Hemodialysis patients aged ≥65 years from the department of Nephrology of the 
University Medical Center Groningen and from the Dialysis Center Groningen with an 
arteriovenous fistula without significant recirculation were eligible for this study. Patients 
with a history of dementia, hydrocephalus, cerebrovascular accident, raised intracranial 
pressure, end-stage liver disease, actively treated cancer, a known significant (>70%) 
internal carotid artery or major intracranial vessel stenosis, and patients with a contra-
indication for MRI were excluded. After study-inclusion, routine Duplex evaluation was 
performed to exclude subjects with an asymptomatic internal carotid artery stenosis of 
more than 70% or major intracranial vessel stenosis, because this may interfere with the 
interpretation of CBF. Patient characteristics were assessed at study entry and retrieved 
from the patients’ medical history. Based on the highly sensitive technique of [15O]H2O and 
based on former studies that mainly used transcranial Doppler in which the number of 
hemodialysis patients varied between 12 and 27, 20-25 we expected that a total of 14 




NIRS monitoring and three PET-CT scans were performed simultaneously during a single, 
regular hemodialysis session after the longest interdialytic interval (Monday or Tuesday). 
All hemodialysis study sessions were performed in the afternoon in the PET-CT camera 
room, with a constant ambient room temperature of 20°C, excluding an effect of outside 
temperature on cardiovascular stability during the study sessions. 
First, NIRS monitoring was started. Next, the first PET-CT scan was performed (T1), 
after which patients started hemodialysis still being in a horizontal position in the PET-CT 
camera. After the second PET-CT scan (T2), which was performed at a mean of 21 minutes 
(range 13-29) after the start of hemodialysis, patients were transferred to a hospital bed 
adjacent to the PET-CT camera to continue dialysis in a 30-45 degrees supine position. 
Before the third PET-CT scan (T3), which was performed at the end of the hemodialysis 
session at mean 209 minutes (range 168-223 minutes) after the start of hemodialysis, 
patients were transferred back to the PET-CT camera. Prior to each PET-CT measurement, 
patients rested in the supine position for at least 20 minutes, thereby reducing the 
influence of postural change on both NIRS and PET measurements. 26, 27 Blood pressure, 
heart rate, and tympanic temperature were measured every 30 minutes and before every 
PET-CT scan. Blood pressure was measured using an automated blood pressure monitor. 
Cerebrovascular resistance was calculated as the mean arterial pressure (MAP) divided by 
the CBF of the frontal gray matter.  For the dialysis settings, see Supplemental file. 
 
NIRS monitoring and analysis 
For NIRS monitoring an In Vivo Optical Spectroscopy device (INVOS™ 5100C 
Cerebral/Somatic Oximeter | Covidien – Medtronic, Minneapolis, USA) was used, with 
sensors placed bilaterally on the patient’s forehead according to the manufacturer’s 
recommendations. The adhesive optodes were connected to the NIRS device and the 
sampling rate was 0.2 Hz. For the analysis of rSO2, we excluded values of zero and excluded 
rSO2 values with a quality score <4, to increase accuracy and exclude movement artifacts. 
Mean rSO2 values were calculated for the 5-minute time periods during which the three 
[15O]H2O PET-CT scans were performed.  
 
PET and MRI acquisition  
For the [15O]H2O PET-CT a Siemens Biograph 64-mCT (Siemens) Medical Systems, 
Tennessee, USA) was used. After performing a low-dose CT scan for attenuation and 
scatter correction, the dynamic PET acquisition (310 sec) was started, followed after 10 sec 
by an intravenous bolus injection of [15O]H2O. The injected dose of [15O]H2O was 500 MBq 
per scan, and 1500 MBq per patient for the study in total. Three of the 36 scans could not 
	
be analyzed due to a technical problem with the automated sampling system (patient-
identity 106 [T1], patient-identity 107 [T2], patient-identity 102 [T3]). 
 To define regional CBF, we also performed magnetic resonance imaging (MRI) in all 
patients using a 1.5T whole body system (Aera, Siemens, Erlangen, Germany) on a separate 
day. The scan protocol included T1-weighted, T2-weighted, three-dimensional fluid-
attenuated inversion recovery, diffusion-weighted imaging, susceptibility weighted 
imaging, and two-dimensional phase contrast sequences. No intravenous contrast was 
used.  
 
Image reconstruction and processing 
Image processing and pharmacokinetic analysis were performed with PMOD 3.8 software 
(PMOD Technologies Ltd., Zurich, Switzerland). The average image (time-weighted) was 
used for rigid matching registration of the individual PET to the individual MRI. The PET list-
mode data were reconstructed using the 3D OSEM algorithm (3 iterations and 24 subsets), 
point spread function correction and time-of-flight, and reconstructed to 28 dynamic 
frames (1×10 sec, 12×5 sec, 6×10sec, and 9×20 sec). Data were corrected for attenuation, 
scatter and radioactivity decay. This resulted in images with a matrix of 400 × 400 × 111 of 
2 mm voxels, smoothed with a 2 mm filter at full width at half maximum. The volumes of 
interest were transformed into the individual space, based on the Hammers atlas and 
limited to the gray matter tissue in the cortical regions (>30% gray matter probability 
based on standard probability). 28 After spatial registration, pharmacokinetic modeling was 
applied to the dynamic PET images to calculate the CBF, based on the implementation of 
the 1-tissue compartment model developed by E. Meyer. 29 Delay of the arterial input 
function and dispersion in the model were first calculated for the whole brain, and then 
these resulting values were fixed for the volumes of interest. For additional information on 
PET processing, see the Supplemental Methods.  
 
Laboratory measurements 
For the laboratory measurements, including hemoglobin, hematocrit, pO2, pCO2, SaO2, and 
pH, arterial blood was sampled from the arterial dialysis line just before each PET-CT scan. 
Arterial O2 content (CaO2) was calculated using the following equation:   
CaO2 (mL/dL) = 1.34 x Hb x (SaO2/100) + (0.0031 x pO2),  30  
where Hb represents the hemoglobin concentration (converted to g/dL), SaO2 represents 
the oxygen saturation (%), and pO2 represents the oxygen pressure (converted to mmHg).  
Markers of inflammation included high sensitive C-reactive protein (CRP), and 
pentraxin-3. Pentraxin-3 responds rapidly to inflammatory stimuli and is considered an 
appropriate marker for the intradialytic inflammatory response. 31  
	
Markers of endothelial activation included angiopoietin-1, angiopoietin-2, the 
angiopoietin 2:1 (AP 2:1) ratio, and von Willebrand factor (vWF). 32-34   
 
Statistical analyses 
First, absolute changes in rSO2, CBF, and clinical and laboratory characteristics were 
studied using linear mixed models (LMM), which allowed for individual random effects. 
The likelihood ratio test was used to determine whether the LMM including a random 
intercept and slope statistically better fitted the data as compared to including a random 
intercept only.   
For the primary study objective, the relative change in rSO2 (ΔrSO2) was compared 
with the relative change in frontal gray matter CBF (ΔCBF) during hemodialysis. We 
decided to study the correlation between relative changes instead of absolute changes, 
because NIRS and PET measure different physiological parameters (oxygenation vs. 
perfusion) and have different units. Besides, we chose the frontal gray matter CBF instead 
of the total (gray and white) frontal lobe CBF, because it has been estimated that 
approximately 85% of rSO2 is derived from more superficial cortical cerebral tissue, thus 
not including frontal white matter. 18 First, ΔrSO2 and ΔCBF were calculated as the mean of 
the individual percent change between T1 and T3 using descriptive statistics, reported as 
mean (%) ± SD. Second, Pearson or Spearman correlation tests, whether appropriate, were 
used to evaluate the correlation between ΔrSO2 and ΔCBF. Finally, we created a Bland-
Altman plot with the difference between ΔCBF and ΔrSO2 as a function of ΔCBF, since PET 
is considered the reference method. 35, 36 95% levels of agreement were calculated as the 
mean of the differences ±1.96*SD. Subsequently, we checked for fixed and proportional 
bias using a T-test and linear regression model, respectively. In an additional analysis, we 
tested the correlation and agreement of ΔrSO2 and ΔCBF between T2 (as a second baseline 
shortly after the start of hemodialysis) and T3, and between T1 and T2. Furthermore, we 
additionally calculated cerebrovascular resistance (CVR) as MAP/ CBF. 
 For the secondary study objective, associations of hemodialysis and oxygenation-
related factors and of markers of inflammation and endothelial activation with rSO2 and 
frontal gray matter CBF were explored. For this objective, we studied absolute instead of 
relative rSO2 and CBF values at all time points using LMM, thereby increasing power since 
this enabled us to use all 33 and 36 measurements of CBF and rSO2, respectively, instead of 
10 and 12 measurements of ΔCBF and ΔrSO2, respectively. Furthermore, rSO2 and CBF 
values of the left and right hemisphere were merged for the analyses, because rSO2 and 
CBF changes did not differ significantly between the left and the right hemisphere. The 
hemodialysis-related factors were defined previously based on literature and included 
mean arterial pressure (MAP), 17 pCO2, 37 pH, 37 tympanic temperature, 38 hematocrit,  20-22, 39, 40 
	
and ultrafiltration (UF) volume and rate.  21, 22  For this study, we additionally studied the 
relation of oxygenation-related factors (CaO2 and pO2) and markers of inflammation (CRP 
and pentraxin-3) and endothelial activation (angiopoietin-1, angiopoietin-2, AP 2:1 ratio 
and vWF) with both rSO2 and frontal gray matter CBF change. All the hemodialysis and 
oxygenation-related factors and markers of inflammation and endothelial activation were 
studied univariately using LMM, checking the significance of interactions with scan-order. 
We did not perform adjusting for multiple testing, because the hemodialysis and 
oxygenation-related factors and markers of inflammation and endothelial activation were 
selected beforehand. 
 In supplementary analyses we repeated the main analyses after excluding one 
outlier. Second, we tested the correlation between the absolute rSO2 and CBF values at all 
time points. Third, we tested the correlation of Δmean frontal-rSO2 (mean of left and right 
rSO2) with Δglobal-CBF (from a volume of interest covering the whole brain). 
 Two-sided P<0.05 was considered statistically significant. Statistical analyses were 
performed with SPSS, version 23 (SPSS Inc, IBM company, USA), Stata/Se 14.2 (StataCorp 




Patient enrolment and characteristics 
Of the 15 patients who gave written informed consent, 12 patients completed the study 
(Table 1). Three patients withdrew from the study, because of a kidney transplantation, hip 
fracture, and withdrawal of consent, respectively. None of the patients had to be excluded 
because of a significant carotid artery stenosis.  
 
Intradialytic NIRS-rSO2 and frontal gray matter PET-CBF changes 
Raw individual rSO2 levels during hemodialysis are shown in Figure 1 for the left and right 
hemisphere. Using LMM, left rSO2 declined from 54.8±5.7% to 51.2±7.3% (absolute 
difference -4.2% [95% CI, -6.6; -1.8]; P=0.001), whereas right rSO2 declined from 54.1±5.2% 
before hemodialysis (T1) to 50.6±7.5% (absolute difference -3.1% [95% CI, -6.4; 0.3]; P=0.08) 
at the end of hemodialysis (T3) (Table 2). Frontal gray matter CBF declined from 44.1±7.8 
mL/100g/min at T1 to 38.3±5.4 mL/100g/min at T3 (absolute difference -5.9 mL/100g/min 
[95% CI, -10.4; -1.5]; P=0.009) in the left hemisphere, and from 44.7±7.7 mL/100g/min at T1 
to 38.8±5.1 mL/100g/min at T3 (absolute difference -6.2 mL/100g/min [95% CI, -10.6; -1.7]; 





Fig 1.  Individual rSO2 trajectories during hemodialysis of the left (1A) and right (1B) hemisphere. 
NIRS/PET measurement 1 was performed at a mean of 18 min (range 15-31 min) before the start of 
hemodialysis. Hemodialysis is regarded as baseline (t=0). Measurement 2 and 3 were performed at 
a mean of 21 minutes (range 13-29 min) and 209 minutes (range 168-223 min) after the start of 
hemodialysis, respectively. Each line represents one patient. 
  
  The relative change in rSO2 between T1 and T3 (ΔrSO2) was mean -8±9% for the left 
and -5±11% for the right hemisphere, respectively. The relative change in frontal gray 
matter CBF between T1 and T3 (ΔCBF) was -11±18% for the left and -12±16% for the right 
hemisphere, respectively. The individual relative changes in ΔMAP, ΔCBF, ΔrSO2 and Δ CVR 
per patient between T1 and T3 are shown in Table S1. ΔrSO2 and ΔCBF were moderately 
correlated for the right hemisphere (ρ 0.69, P=0.03), but weakly correlated for the left 







 Fig 2. Correlation between Δ rSO2 and Δ Frontal gray matter Cerebral Blood Flow of the left (2A) 
and right (2B) hemisphere, calculated between T3 and T1. Correlation coefficient for the left 
hemisphere: ρ 0.31 (P=0.4), and the right hemisphere: ρ 0.69 (P=0.03).  
 
The Bland-Altman plot showed moderate agreement (Figure 3). The overall bias was -
3±16% (P=0.5) for the left and -5±12% (P=0.2) for the right hemisphere (Figure 3). 
Furthermore, linear regression suggested a proportional bias, indicating underestimation 
of ΔCBF by NIRS with larger CBF increases or decreases.  
 
 
Fig 3. Bland-Altman plot of % changes in rSO2 (ΔrSO2) and in CBF (ΔCBF) between T1 (before 
hemodialysis) and T3 (at the end of hemodialysis), displayed for the left (3A) and right (3B) 
hemisphere. The X-axis represents ΔCBF (%), while the Y-axis represents the difference between 
ΔCBF and ΔrSO2. The central solid line represents zero bias. The central dashed line indicates 
overall bias, which is -3% for the left, and -5% for the right hemisphere, calculated as the mean of 
the differences, while the lower and upper dashed lines represent limits of agreement: -35% and 
29% for the left, and -28% and 17% for the right hemisphere, respectively. Linear regression 
suggested the presence of proportional bias (left hemisphere: P=0.003, regression equation: Y= 5.1 
	
+ 0.8x; right hemisphere: P=0.03, regression equation: Y= 0.6 + 0.5x. This indicates that NIRS 
increasingly underestimated ΔCBF with large(r) changes in CBF. 
 
One patient showed a large increase in CBF (patient-id 110) and could be regarded 
as an outlier, although it is unknown whether a 30-40% increase in CBF is physiologically 
implausible during hemodialysis. After removal of this outlier, the correlation coefficients 
were almost similar (correlation ΔrSO2 and ΔCBF left hemisphere: ρ 0.30 (P=0.4), and right 
hemisphere: ρ 0.64 (P=0.06). However, removal of this outlier changed the Bland-Altman 
analysis yielding an (almost) significant fixed bias now, instead of a proportional bias (left 
hemisphere: fixed bias -7% (P=0.09), lower and upper limits of agreement -29% and 14%; 
right hemisphere: fixed bias -8% (P=0.03), lower and upper limits of agreement -25% and 
9%). 
Additionally, we studied ΔrSO2 and ΔCBF between T2 and T3, and between T1 and 
T2. Between T2 and T3, the correlation between ΔrSO2 and ΔCBF was moderate for the left 
(ρ 0.64, P=0.048) and strong for the right hemisphere (ρ 0.76, P=0.01) (Figure S1). The 
agreement plot was almost similar as for T1 vs. T3, and linear regression again suggested 
proportional bias (Figure S2).  Between T1 and T2, ΔrSO2 and ΔCBF did not correlate for 
both hemispheres (Figure S3), and the agreement plot again suggested proportional bias 
(Figure S4).   
Supplementary analyses showed no significant correlation between ΔMAP and 
ΔrSO2 (Figure S5), or between ΔMAP and ΔCBF (Figure S6). Second, using LMM, CVR did 
not change significantly during hemodialysis, and no significant correlation between ΔCVR 
and ΔrSO2 was found (Figure S7). Third, no significant correlation between the absolute 
rSO2 and absolute CBF values at any time point was found (Figure S8). Finally, defined as T1 
versus T3, Δmean-frontal rSO2 (mean of left and right ΔrSO2) and Δglobal-CBF (the whole 
brain as region of interest) were non-significantly correlated (ρ 0.51, P=0.1). Defined as T2 
versus T3, Δmean-frontal rSO2 and Δglobal-CBF showed a strong correlation (ρ 0.72, 
P=0.02). 
 
Associations of hemodialysis-related factors with NIRS-rSO2 and frontal gray matter 
PET-CBF 
The mean UF volume, i.e. the fluid volume that was removed during hemodialysis, was 
1934±781 mL, and the mean UF rate, i.e. the rate of fluid removal, was 6.7±2.5 mL/h/kg 
body weight. During hemodialysis, blood pH, tympanic temperature and hematocrit 
increased significantly, whereas the MAP did not change significantly (Table 3). 
A significant interaction of pH with scan-order was present for the associations 
between pH and rSO2, and between pH and CBF. A higher blood pH was associated with a 
	
higher rSO2 at T3, as compared to T1, but with a lower CBF (Table 4; for detailed 
information on the interaction effects and confidence intervals, see Table S2). A higher 
hematocrit was significantly associated with a higher rSO2 at T2 and T3 as compared to T1, 
but not with CBF. MAP, tympanic temperature, and UF volume were not associated with 
rSO2, whereas tympanic temperature and UF volume had a significant negative effect on 
CBF.  
 
Associations of oxygenation-related factors, and markers of inflammation and 
endothelial activation with NIRS-rSO2 and frontal gray matter PET-CBF 
CaO2 and pentraxin-3 increased significantly during hemodialysis. Intradialytic pCO2, pO2, 
CRP, and the endothelial activation markers did not change significantly (Table 3).  
Of the oxygenation-related markers, a higher pCO2 was significantly associated with 
a lower rSO2 at T2, as compared to T1. Conversely, a higher pCO2 was significantly 
associated with a higher CBF (Table 4). Higher pO2 was significantly associated with higher 
rSO2, whereas the association between pO2 and CBF yielded different effects over time 
(Table 4). CaO2 was positively associated with rSO2 whereas it was negatively associated 
with CBF. The inflammation markers were not associated with rSO2 or CBF. Of the 
endothelial activation markers, a higher angiopoietin-2 and AP 2:1 ratio was associated 
with a lower rSO2, and a higher vWF was associated with a higher rSO2. None of the 
endothelial activation makers had an association with CBF. 
 
Adverse event 
One patient (identity 115) lost consciousness due to dialysis-induced hypotension shortly 
after the third NIRS/PET measurement. The mean decline in CBF of left and right frontal 
gray matter was 23% (both hemispheres -23%) and the mean frontal rSO2 decline was 27% 





In this study, we found a moderate correlation between frontal ΔrSO2 as measured with 
NIRS and ΔCBF of the frontal gray matter as measured with [15O]H2O PET during 
hemodialysis. The agreement analysis showed moderate agreement and a trend towards 
predominantly a fixed bias with underestimation of ΔCBF by NIRS. Thus, NIRS could be a 
proxy for PET to capture intradialytic CBF changes, but some correction factor may be 
needed to correct for the underestimation of ΔCBF by NIRS. Furthermore, considerable 
differences were noted with regard to associations of hemodialysis- and oxygenation-
	
related factors and markers of endothelial activation with rSO2 as compared to CBF. This 
underscores that rSO2 and CBF represent different physiological parameters of the brain. 
Few studies have simultaneously performed cerebral oximetry and PET scanning. 
One study evaluated the change in cerebral blood volume (ΔCBV) as measured by NIRS, 
with ΔCBV as measured by PET, during normoventilation and during pCO2 manipulation 
procedures. 41 They reported a moderate correlation (ρ =0.56) between ΔCBV-NIRS and 
ΔCBV-PET, and an underestimation of ΔCBV by NIRS. Villringer et al. compared changes in 
rSO2 by NIRS with simultaneous changes in PET-CBF during rest and during cognitive 
activation tasks. They found a strong correlation (ρ =0.88) between Δtotal-Hb (i.e., the sum 
of Δoxy-Hb and Δdeoxy-Hb) and ΔCBF, if a penetration depth of near-infrared light of 0.9 
cm into the brain cortex was assumed. 42 Another study from the same group showed 
strong correlations of Δoxy-Hb (ρ range: 0.74 to 0.75), Δdeoxy-Hb (ρ range: -0.64 to -0.69), 
and Δtotal-Hb (ρ range: 0.88 to 0.93) with ΔCBF, when assuming various penetration 
depths ≤1.35 cm of near-infrared light. 43 Several differences limit the comparison of their 
findings to ours. First, Villringer et al. compared NIRS to frontal CBF of a small semisphere, a 
so-called ‘banana-shaped’ region behind the NIRS optode. In contrary, we studied the 
correlation of NIRS with CBF of the total frontal gray matter. Second, Villringer et al. did not 
describe the correlation between ΔrSO2 (i.e., Δoxy-Hb/Δdeoxy-Hb) and ΔCBF. Besides, 
neither the studies from this group nor other studies investigated patients with CKD or 
encompassed the hemodialysis process. 
 The hemodialysis process is a unique physiological stimulus involving many 
simultaneous hemodynamic and metabolic changes, 44 e.g. a change in pH due to 
bicarbonate infusion that is not necessarily accompanied by simultaneous changes in 
pCO2 or pO2. Previous studies reported either no change in rSO2 during hemodialysis, 45, 46  
or an rSO2 decline only during the first 35 minutes of hemodialysis, with a subsequent 
increase in rSO2 yielding a net non-significant change at the end of hemodialysis. 47 Our 
study is new insofar that we simultaneously studied intradialytic changes in rSO2 by NIRS 
and changes in CBF by PET. 
 There is increasing interest in the utilization of NIRS to monitor adequacy of brain 
perfusion non-invasively. The underlying assumption is that changes in rSO2 reflect 
changes in CBF, which is theoretically correct if cerebral metabolism, CBV, and additionally 
CaO2, blood transit time, and oxygen extraction fraction (OEF) remain constant. 48  
However, to our knowledge, it is unknown whether this is true during the hemodialysis 
procedure. First, absolute systemic blood volume was reported to decline by 17% during 
hemodialysis, 49 but it is unknown whether CBV also declines. Second, during hemodialysis 
10% of the patients of a hemodialysis cohort experienced prolonged hypoxia (arterial 
oxygen saturation <90% at least one third of the treatment time). 50 Third, apart from an 
	
intradialytic effect, it was reported that cerebral oxygen metabolism, 51 blood transit time, 52  
and oxygen extraction, 51 were altered in hemodialysis patients compared to controls. 
Nevertheless, since our primary study aim was to evaluate the correlation between ΔrSO2 
and ΔCBF, we are not able to draw any conclusion on the other parameters such as CBV, 
OEF, or blood transit time.  
The underestimation of CBF changes by NIRS seems to be related to predominantly 
a fixed bias, since with removal of one outlier no proportional bias was present anymore. 
The underestimation of ΔCBF by NIRS could be the result of scattering effects of 
extracerebral tissue on the transmission of light. Computer modeling showed that in a 
typical tissue volume interrogated by NIRS, approximately 30% was brain and 70% was 
extracerebral tissue. 53    
  Remarkably, we noted an absent correlation between ΔrSO2 and ΔCBF, defined as 
T1 versus T2 including the first 30 minutes of hemodialysis. Previous studies reported that 
PaO2 initially declined during the first 60 minutes of hemodialysis treatment. 50, 54 We 
speculate that early intradialytic changes in PaO2 influenced ΔrSO2 rather than ΔCBF 
between T1 and T2 thereby limiting the correlation. Of note, the divergent association of 
PaO2 with rSO2 as compared to CBF seems to underscore this hypothesis. 
Another remarkable finding was the left-right asymmetry in the correlation and 
Bland-Altman analyses. Because removal of one outlier did not change this asymmetry, we 
consider this asymmetry a change finding. 
We found that on average CVR did not change significantly during hemodialysis. 
This constant CVR could suggest that static autoregulation might have been disturbed. 
However, we cannot draw any definite conclusions, since this was not an autoregulation 
study and many factors change simultaneously during hemodialysis (e.g. pH, hematocrit), 
which might directly affect CVR. 
 Four patients experienced an rSO2 drop of >20% during hemodialysis. A 20% rSO2 
decline has been proposed as predictor of cerebral ischemia in patients during carotid 
endarterectomy and cardiac surgery. 55, 56 A >15% drop in rSO2 during hemodialysis was 
shown to correlate with executive function decline at 1-year follow-up. 17 Therefore, 
although NIRS tended to underestimate PET-CBF with increasing CBF changes, in our 
opinion NIRS is still a promising technique to monitor declines in cerebral oxygenation 
during hemodialysis. Intradialytic changes in cerebral oxygenation might yield important 
information on intradialytic brain homeostasis, apart from intradialytic changes in cerebral 
perfusion. More studies are needed to explore whether large intradialytic rSO2 drops are 
associated with incident cerebral ischemic injury and decline of cognitive function during 
follow-up.  
 The second aim of this study was to explore associations of several clinical and 
	
laboratory parameters with rSO2 as compared to CBF. No association of MAP with rSO2 was 
found, similar to previous studies. 45, 46 Remarkably, pH was positively associated with rSO2 
and negatively with CBF. The positive association of pH with rSO2 might be explained by a 
leftward shift of the oxygen-hemoglobin dissociation curve due to the increase in pH 
during dialysis, thereby theoretically increasing rSO2. However, others have reported a 
negative association of pH with rSO2 in dialysis patients. 57 Further examination is required 
on the effects of pH on CBF and rSO2 during hemodialysis, especially because the 
intradialytic change in pH is a modifiable factor by lowering the bicarbonate concentration 
in the dialysate. 
 To our knowledge, potential associations of inflammation and endothelial 
activation markers with cerebral tissue oxygenation have not been reported previously. 
We found an association between endothelial activation markers and rSO2, since a higher 
angiopoietin-2 and angiopoietin 2:1 ratio was associated with lower rSO2. Angiopoietin-1 
stabilizes the endothelium, whereas angiopoietin-2 functions as a vessel-destabilizing 
molecule. 58  A higher angiopoietin 2:1 ratio seems to represent loss of endothelial barrier 
integrity,  59 and might be an early marker of endothelial activation and dysfunction. 60, 61  A 
possible explanation for the association between angiopoietin-2, and the angiopoietin 2:1 
ratio with rSO2 might be found in the lungs. Recently, angiopoietin-2, which is stored in 
pulmonary epithelial cells, was suggested to have effects on gas exchange. 62 Nevertheless, 
the relation between angiopoietin-2 and the angiopoietin 2:1 ratio and rSO2 needs further 
examination, and is beyond the scope of this study. 
 There are a number of potential weaknesses to this study. The sample size of this 
study was small and one outlier might have had a relative large influence in the analyses. 
Furthermore, the findings on our second study aim, i.e., associations of hemodialysis and 
oxygenation-related factors, and inflammation and endothelial activation markers with 
rSO2 and CBF, should be purely considered as hypothesis generating. Larger studies are 
needed to evaluate the effect size of various factors and markers dynamically by 
multivariate analysis, especially because various hemodynamic, metabolic, and laboratory 
characteristics change simultaneously during hemodialysis. Second, NIRS and CBF 
measurements were performed in a supine position, whereas in general patients are in a 
semi-upright sitting position during hemodialysis. A semi-upright sitting position might 
have changed the rSO2 and CBF values but should not alter the correlation between both. 
Third, for a future study the use of a NIRS device that provides oxyHb, deoxyHb and total 
Hb levels is advised, because oxyHb better relates to arterial inflow than rSO2, which is a 
mix of arterial and venous circulation. Besides, such study might also provide more 
information on transit time (changes) during hemodialysis, which we were not able to take 
into account.  
	
In conclusion, NIRS could be used as a proxy to PET to detect intradialytic CBF 
changes, but a correction factor may be needed to correct for the underestimation of CBF 
changes by NIRS. The different associations of hemodialysis- and oxygenation-related 
factors and markers of endothelial activation with rSO2 as compared to CBF underscore 
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Table 1 Patient characteristics (N=12) 
Age (yr) 75.4 ± 5.2 
Men (%) 7 (58%) 
BMI (kg/m2) 26.6 ± 3.5 
Primary kidney disease: (%)  
   Glomerulonephritis 4 (33%) 
   Diabetes 1 (8%) 
   Vascular 3 (25%) 
   Other diagnosis 3 (25%) 
   Unknown 1 (8%) 
Current smoker 4 (33%) 
Diabetes 3 (25%) 
Hypertension 11 (73%) 
Myocardial infarction 2 (17%) 
Heart failure 1 (8%) 
Peripheral artery disease 1 (8%) 
COPD 1 (8%) 
Medication:  
   CCB 4 (33%) 
   Nitrate  3 (25%) 
   ACE inhibitor 1 (8%) 
   Angiotensin receptor blocker 1 (8%) 
   Beta-blocker 9 (75%) 
Data are presented as means ± SD or (range), or number and percentages (%).ACE: angiotensin-
converting enzyme; BMI: body mass index; CBF: cerebral blood flow; CCB: calcium channel blocker. 
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51.6 ± 5.7 
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36.3 ± 0.5 
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Additional information on Dialysis Settings 
All patients were on bicarbonate dialysis with a low-flux polysulfone hollow-fiber dialyzer 
(F8; Fresenius Medical Care, Bad Homburg, Germany). Blood flow and dialysate flow rates 
were 200-300 and 500 mL/min, respectively. Dialysate temperature was 36.5°C in all 
patients. We used constant UF rate and dialysate conductivity. Dialysate composition was 
sodium 139 mmol/L, potassium 1.0 or 2.0 mmol/L depending on the prevailing plasma 
potassium, calcium 1.5 mmol/L, magnesium 0.5 mmol/L, chloride 108 mmol/L, bicarbonate 
34 mmol/L, acetate 3.0 mmol/L, and glucose 1.0 g/L. The water for hemodialysis complied 
with the requirements of the European Pharmacopoeia (<100 colony-forming units/mL; 
<0.25 endotoxin units/mL).  
 
Additional information on Image Reconstruction and Preprocessing  
We used the 3D T2-FLAIR images for the registration process, because the 3D acquisition of 
the T1-weighted sequence was not available. Furthermore, several patients had marked 
brain atrophy and white matter lesions. Therefore, we used the population-based gray 
matter/white matter (GM/WM) maps to segment the cortical tissue, instead of using the 
subject probability maps. This means that the cortical volumes of interest (VOIs) are 
slightly larger than when the individual maps for the subject are used. Since we did the 
modeling in the subject brain space (no deformations to adjust to the atlas) and the VOIs 
were based on the population-based GM/WM probabilities, the effect of the atrophy and 
lesions is expected to be minimal. 
	 Supplem
entary Figure S1 Correlation of Δ rSO
2  and Δ Frontal gray m
atter Cerebral Blood Flow
 betw




  Fig S1. Scatter plots of Δ Cerebral Blood Flow
 (X-axis) and Δ Regional O
xygen Saturation (Y-axis) calculated betw
een T3 and T2, displayed per left (S1A) 
and right (S1B) hem
isphere. Correlation coefficient for the left hem
isphere: ρ 0.64 (P=0.048), and the right hem
isphere: ρ 0.76 (P=0.01).  
 
	 Supplem
ental Figure S2 Bland-Altm
an plot of N
IRS-estim
ated versus PET-based CBF change betw
een T2 and T3 
 
 
 Fig S2. Bland-Altm
an plot of changes in rSO
2  (ΔrSO
2 ) and in CBF (ΔCBF) betw
een T2 (early after start of hem
odialysis) and T3 (at the end of hem
odialysis), 
displayed for the left (S2A) and right (S2B) hem
isphere. The X-axis represents ΔCBF (%
), w
hile the Y-axis represents the difference betw
een ΔCBF and 
ΔrSO
2 . The central solid line represents zero bias. The central dashed line indicates overall bias, w
hich w





, P=0.2). The upper and low




 for the left, and -33%
 and 17%
 for the right 
hem
isphere, respectively. Linear regression m
odeling suggested the presence of proportional bias (left hem
isphere: P=0.001, regression equation: Y= -
0.5 + 0.7x; right hem
isphere: P=0.01, regression equation: Y= -3.3 + 0.5x). This suggests that N
IRS increasingly underestim
ated ΔCBF w
ith large(r) changes 
in CBF. 
	 Supplem
ental Figure S3 Correlation of Δ rSO
2  and Δ Frontal gray m
atter Cerebral Blood Flow
 betw
een T1 and T2 
   
 
 
   Fig S3. Scatter plots of Δ Cerebral Blood Flow
 (X-axis) and Δ Regional O
xygen Saturation (Y-axis) calculated betw
een T2 and T1, displayed per left (S3A) 
and right (S3B) hem
isphere. Correlation for the left hem
isphere: ρ -0.09 (P=0.4), and the right hem
isphere: ρ -0.21 (P=0.6).  
	 Supplem
ental Figure S4 Bland-Altm
an plot of N
IRS-estim
ated versus PET-based CBF change betw
een T1 and T2 
 
 
 Fig S4. Bland-Altm
an plot of changes in rSO
2  (ΔrSO
2 ) and in CBF (ΔCBF) betw
een T1 (before start of hem
odialysis) and T2 (early after start of 
hem
odialysis), displayed for the left (S4A) and right (S4B) hem
isphere. The X-axis represents ΔCBF (%
), w
hile the Y-axis represents the difference betw
een 
ΔCBF and ΔrSO
2 . The central solid line represents zero bias. The central dashed line indicates overall bias, w
hich w





, P=0.4). The upper and low








isphere, respectively. Linear regression suggested the presence of proportional bias (left hem
isphere: P=0.004, regression equation: Y= 7.0 
+ 1.3x, right hem
isphere: P<0.001, regression equation: Y= 5.9 +1.3x). This suggests that N
IRS increasingly underestim
ated ΔCBF w




ental Figure S5 Correlation betw
een absolute values of rSO
2  and Frontal gray m
atter Cerebral Blood Flow
 
  
   
 
 
Fig S5. Scatter plots of frontal gray m
atter CBF (X-axis) and regional oxygen saturation (Y-axis) at T1, T2, and T3, and displayed per left and right 
hem
isphere. N
o significant correlations w
ere found. 
	 Supplem
ental Table S1 Associations of H
em
odialysis and O
xygenation-related factors, and of Inflam
m





2  (left panel), and frontal gray m
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H
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 (per 0.1 change) 
-1.2 (-6.4; 3.9) 
6.2 (1.2; 11.1)* 
8.4 (0.7; 16.1)* 
 
7.4 (2.5; 12.2)** 
-10.2 (-13.5; -6.8)*** 
-22.9 (-36.0; -9.8)** 
H
em
atocrit (per 0.1 m
m
ol/L) 
8.6 (1.4; 15.7)* 
-4.7 (-9.3; -0.1)* 




















0.3 (-1.0; 1.5) 
-0.8 (-1.4; -0.1)* 
-0.9 (-2.2; 0.3) 
 





















2  (kPa) 




-2.3 (-2.9; -1.8)*** 
0.9 (0.4; 1.4)** 
2.7 (1.6; 3.9)*** 
pCO
2  (kPa) 
-0.4 (-4.5; 3.7) 
-4.7 (-8.5; -1.0)* 
-5.7 (-12.2; 0.8) 
 






2.0 (0.3; 3.7)* 
-1.1 (-2.2; -0.002) 
-1.7 (-3.3; -0.01)* 
 
-2.7 (-5.0; -0.4)* 
1.3 (0.1; 2.4)* 



















-0.9 (-1.7; -0.1)* 
-0.2 (-0.8; 0.4) 






Angiopoietin 2:1 ratio 




















ere studied using linear m
ixed effects m
odels including a random
 intercept, or a random
 intercept and slope, w
hether appropriate according the likelihood-ratio test. The 
estim
ated effect (95%
CI) of the individual characteristics on frontal rSO
2  and frontal gray m
atter is presented. *P<0.05, **P<0.01, *** P<0.001. The m
odels w
ith an interaction could be 
interpreted by adding the overall effect to the interaction effect, e.g. a 0.1 pH
 increase is associated w
ith a (-1.2 + 6.2=) 5%
 rSO
2  increase at T2, and a (-1.2 +8.4=) 7.2%
 rSO






ation (pentraxin-3, and CRP) w
ere not associated w
ith rSO
2  or CBF. § The analysis of m
ean arterial pressure and CBF w
as inconclusive due to 
patient variation and m
issing values.  20  CaO
2 , arterial oxygen content; N
A, not available; rSO
2 , regional oxygen saturation.  
  
